SUMMIT THERAPEUTICS INC COM - Stock (SMMT)

CUSIP: 86627R102

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Stock
Total 13F shares
2,594,256
Share change
-287,868
Total reported value
$4,749,000
Price per share
$1.83
Number of holders
12
Value change
-$215,622
Number of buys
9
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 86627R102?
CUSIP 86627R102 identifies SMMT - SUMMIT THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q1 2019

As of 31 Mar 2019, SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,594,256 shares. The largest 10 holders included LANSDOWNE PARTNERS (UK) LLP, Polar Capital LLP, MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, SeaCrest Wealth Management, LLC, DEUTSCHE BANK AG\, and Virtu Financial LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.